Organization | Sheikh Khalifa Medical City

Sheikh Khalifa Medical City Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial

2003

NCT00151905

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Sheikh Khalifa Medical City

Active Ingredients

Drugs in Phase 3 Trials (5)

bbibp-corv (1 trial)

covid-19 vaccine (vero cells) (1 trial)

matrix m1 (1 trial)

nvx-cov2373 (Covovax) (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (1)

dexmedetomidine (precedex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Bronchiolitis (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 4
# of Trial APIs: 6